Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF

被引:1
作者
Jimenez-Vicente, Carlos [1 ,2 ,3 ]
Martinez-Roca, Alexandra [1 ,2 ]
Pomares, Helena [2 ,4 ]
Castano-Diez, Sandra [1 ,2 ]
Guijarro, Francesca [2 ,5 ]
Lopez-Guerra, Monica [2 ,5 ,6 ]
Bataller, Alex [1 ,2 ,7 ]
Esteban, Daniel [1 ,2 ]
Cortes-Bullich, Albert [1 ,2 ]
Perez-Valencia, Amanda Isabel [1 ,2 ]
Guardia-Torrelles, Ares [1 ]
Zugasti, Ines [1 ]
Rovira, Montserrat [1 ,2 ,3 ]
Fernandez-Aviles, Francesc [1 ,2 ]
Colomer, Dolors [2 ,5 ]
Arnan, Montserrat [2 ,4 ]
Diaz-Beya, Marina [1 ,2 ,7 ]
Esteve, Jordi [1 ,2 ,3 ,7 ,8 ]
机构
[1] Hosp Clin Barcelona, Hematol Dept, Barcelona, Spain
[2] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain
[3] Univ Barcelona, Barcelona, Spain
[4] Univ Barcelona, Hosp Duran i Reynals, Inst Catala Oncol, Hematol Dept, Barcelona, Spain
[5] Hosp Clin Barcelona, Pathol Dept, Hemopathol Unit, Barcelona, Spain
[6] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
[7] Josep Carreras Leukemia Res Inst, Barcelona, Spain
[8] Hosp Clin Barcelona, Dept Hematol, Villarroel 170, Barcelona 08036, Spain
关键词
AML; Preemptive treatment; MRD; REMISSION; AZACITIDINE;
D O I
10.1016/j.leukres.2023.107403
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:6
相关论文
共 15 条
[1]   Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis [J].
Buckley, Sarah A. ;
Wood, Brent L. ;
Othus, Megan ;
Hourigan, Christopher S. ;
Ustun, Celalettin ;
Linden, Michael A. ;
DeFor, Todd E. ;
Malagola, Michele ;
Anthias, Chloe ;
Valkova, Veronika ;
Kanakry, Christopher G. ;
Gruhn, Bernd ;
Buccisano, Francesco ;
Devine, Beth ;
Walter, Roland B. .
HAEMATOLOGICA, 2017, 102 (05) :865-873
[2]   Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia [J].
Chua, Chong Chyn ;
Hammond, Danielle ;
Kent, Andrew ;
Tiong, Ing Soo ;
Konopleva, Marina Y. ;
Pollyea, Daniel A. ;
DiNardo, Courtney D. ;
Wei, Andrew H. .
BLOOD ADVANCES, 2022, 6 (13) :3879-3883
[3]   Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia [J].
DiNardo, C. D. ;
Jonas, B. A. ;
Pullarkat, V. ;
Thirman, M. J. ;
Garcia, J. S. ;
Wei, A. H. ;
Konopleva, M. ;
Doehner, H. ;
Letai, A. ;
Fenaux, P. ;
Koller, E. ;
Havelange, V. ;
Leber, B. ;
Esteve, J. ;
Wang, J. ;
Pejsa, V. ;
Hajek, R. ;
Porkka, K. ;
Illes, A. ;
Lavie, D. ;
Lemoli, R. M. ;
Yamamoto, K. ;
Yoon, S. -S. ;
Jang, J. -H. ;
Yeh, S. -P. ;
Turgut, M. ;
Hong, W. -J. ;
Zhou, Y. ;
Potluri, J. ;
Pratz, K. W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) :617-629
[4]   Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia [J].
DiNardo, Courtney D. ;
Lachowiez, Curtis A. ;
Takahashi, Koichi ;
Loghavi, Sanam ;
Kadia, Tapan ;
Daver, Naval ;
Xiao, Lianchun ;
Adeoti, Maria ;
Short, Nicholas J. ;
Sasaki, Koji ;
Wang, Sa A. ;
Borthakur, Gautam ;
Issa, Ghayas ;
Maiti, Abhishek ;
Alvarado, Yesid ;
Pemmaraju, Naveen ;
Bravo, Guillermo Montalban ;
Masarova, Lucia ;
Yilmaz, Musa ;
Jain, Nitin ;
Andreeff, Michael ;
Garcia-Manero, Guillermo ;
Kornblau, Steven ;
Ravandi, Farhad ;
Jabbour, Elias ;
Konopleva, Marina Y. ;
Kantarjian, Hagop M. .
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) :1035-1043
[5]   Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine [J].
Doehner, Hartmut ;
Wei, Andrew H. ;
Roboz, Gail J. ;
Montesinos, Pau ;
Thol, Felicitas R. ;
Ravandi, Farhad ;
Dombret, Herve ;
Porkka, Kimmo ;
Sandhu, Irwindeep ;
Skikne, Barry ;
See, Wendy L. ;
Ugidos, Manuel ;
Risueno, Alberto ;
Chan, Esther T. ;
Thakurta, Anjan ;
Beach, C. L. ;
de Menezes, Daniel Lopes .
BLOOD, 2022, 140 (15) :1674-1685
[6]   Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].
Doehner, Hartmut ;
Estey, Elihu ;
Grimwade, David ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Dombret, Herve ;
Ebert, Benjamin L. ;
Fenaux, Pierre ;
Larson, Richard A. ;
Levine, Ross L. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel ;
Sierra, Jorge ;
Tallman, Martin S. ;
Tien, Hwei-Fang ;
Wei, Andrew H. ;
Lowenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2017, 129 (04) :424-447
[7]  
Dohner H., 2022, 64 ASH ANN M EXP INT
[8]   2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party [J].
Heuser, Michael ;
Freeman, Sylvie D. ;
Ossenkoppele, Gert J. ;
Buccisano, Francesco ;
Hourigan, Christopher S. ;
Ngai, Lok Lam ;
Tettero, Jesse M. ;
Bachas, Costa ;
Baer, Constance ;
Bene, Marie-Christine ;
Bucklein, Veit ;
Czyz, Anna ;
Denys, Barbara ;
Dillon, Richard ;
Feuring-Buske, Michaela ;
Guzman, Monica L. ;
Haferlach, Torsten ;
Han, Lina ;
Herzig, Julia K. ;
Jorgensen, Jeffrey L. ;
Kern, Wolfgang ;
Konopleva, Marina Y. ;
Lacombe, Francis ;
Libura, Marta ;
Majchrzak, Agata ;
Maurillo, Luca ;
Ofran, Yishai ;
Philippe, Jan ;
Plesa, Adriana ;
Preudhomme, Claude ;
Ravandi, Farhad ;
Roumier, Christophe ;
Subklewe, Marion ;
Thol, Felicitas ;
van de Loosdrecht, Arjan A. ;
van der Reijden, Bert A. ;
Venditti, Adriano ;
Wierzbowska, Agnieszka ;
Valk, Peter J. M. ;
Wood, Brent L. ;
Walter, Roland B. ;
Thiede, Christian ;
Dohner, Konstanze ;
Roboz, Gail J. ;
Cloos, Jacqueline .
BLOOD, 2021, 138 (26) :2753-2767
[9]   Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens [J].
Lachowiez, Curtis A. ;
Loghavi, Sanam ;
Kadia, Tapan M. ;
Daver, Naval ;
Borthakur, Gautam ;
Pemmaraju, Naveen ;
Naqvi, Kiran ;
Alvarado, Yesid ;
Yilmaz, Musa ;
Short, Nicholas ;
Ohanian, Maro ;
Pierce, Sherry R. ;
Patel, Keyur P. ;
Qiao, Wei ;
Ning, Jing ;
Sasaki, Koji ;
Takahashi, Koichi ;
Jabbour, Elias ;
Andreeff, Michael ;
Ravandi, Farhad ;
Kantarjian, Hagop M. ;
Konopleva, Marina ;
DiNardo, Courtney D. .
BLOOD ADVANCES, 2020, 4 (07) :1311-1320
[10]   Impact of Venetoclax and Azacitidine in Treatment-Naive Patients with Acute Myeloid Leukemia and IDH1/2 Mutations [J].
Pollyea, Daniel A. ;
DiNardo, Courtney D. ;
Arellano, Martha L. ;
Pigneux, Arnaud ;
Fiedler, Walter ;
Konopleva, Marina ;
Rizzieri, David A. ;
Smith, B. Douglas ;
Shinagawa, Atsushi ;
Lemoli, Roberto M. ;
Dail, Monique ;
Duan, Yinghui ;
Chyla, Brenda ;
Potluri, Jalaja ;
Miller, Catherine L. ;
Kantarjian, Hagop M. .
CLINICAL CANCER RESEARCH, 2022, 28 (13) :2753-2761